Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion
Chris J. Frangieh(Broad Institute), Johannes C. Melms(Columbia University Irving Medical Center), Pratiksha I. Thakore(Broad Institute), Kathryn R. Geiger-Schuller(Broad Institute), Patricia Ho(Columbia University Irving Medical Center), Adrienne Luoma(Dana-Farber Cancer Institute), Brian Cleary(Broad Institute), Livnat Jerby-Arnon(Broad Institute), Shruti Malu(Immunitas Therapeutics (United States)), Michael S. Cuoco(Broad Institute), Maryann Zhao(Broad Institute), Casey R. Ager, Meri Rogava(Columbia University Irving Medical Center), Lila Hovey(Broad Institute), Asaf Rotem(Dana-Farber Cancer Institute), Chantale Bernatchez(The University of Texas MD Anderson Cancer Center), Kai W. Wucherpfennig(Dana-Farber Cancer Institute), Bruce E. Johnson(Dana-Farber Cancer Institute), Orit Rozenblatt–Rosen(Broad Institute), Dirk Schadendorf(Essen University Hospital), Aviv Regev(Broad Institute), Benjamin Izar(Columbia University Irving Medical Center)
Cited by 263Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis